Difference between revisions of "Team:BGU Israel"

 
(14 intermediate revisions by 3 users not shown)
Line 60: Line 60:
 
                               <li><img src="https://static.igem.org/mediawiki/2015/5/5c/BGU_home_slider_team4.jpg" /></li>
 
                               <li><img src="https://static.igem.org/mediawiki/2015/5/5c/BGU_home_slider_team4.jpg" /></li>
 
                               <li><img src="https://static.igem.org/mediawiki/2015/6/6a/BGU_home_slider_team5.jpg" /></li>
 
                               <li><img src="https://static.igem.org/mediawiki/2015/6/6a/BGU_home_slider_team5.jpg" /></li>
 +
                              <li><img src="https://static.igem.org/mediawiki/2015/b/b6/BGU_home_slider_team6.jpg" /></li>
 
                           </ul>
 
                           </ul>
 
          
 
          
Line 67: Line 68:
 
             <table style="width: 100%; border-style: hidden;" >
 
             <table style="width: 100%; border-style: hidden;" >
 
                 <tr style="border-style: hidden;">
 
                 <tr style="border-style: hidden;">
 +
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Achievements" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/1/17/BGU_home_icon_trophy.png" alt=""></a></div></td>
 +
 
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Description"><div align="center"><img src="https://static.igem.org/mediawiki/2015/3/3d/Bgu_project.png" alt=""></a></div></td>
 
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Description"><div align="center"><img src="https://static.igem.org/mediawiki/2015/3/3d/Bgu_project.png" alt=""></a></div></td>
  
−
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Achievements" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/1/17/BGU_home_icon_trophy.png" alt=""></a></div></td>
+
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Design" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/6/6b/Bgu_brush-pencil.png" alt=""></a></div></td>
  
−
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Entrepreneurship"><div align="center"><img src="https://static.igem.org/mediawiki/2015/b/b9/BGU_home_icon_briefcase.png" alt=""></a></div></td>
+
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_IsraelResults"><div align="center"><img src="https://static.igem.org/mediawiki/2015/b/b0/Bgu_brightness.png" alt=""></a></div></td>
 +
<!-- https://static.igem.org/mediawiki/2015/b/b9/BGU_home_icon_briefcase.png -->
  
 
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Practices" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/8/89/BGU_Rgb.png" alt=""></a></div></td>
 
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Practices" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/8/89/BGU_Rgb.png" alt=""></a></div></td>
  
−
<td style="border-style: hidden;"><a href=https://2015.igem.org/Team:BGU_Israel/Safety" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/b/b6/BGU_home_icon_hazard.png" alt=""></a></div></td>
+
 
  
 
               </tr>
 
               </tr>
 
               <tr style="border-style: hidden;">
 
               <tr style="border-style: hidden;">
−
                    <td style="text-align: left; border-style: hidden;"><div align="center">Project description</div></td>
 
 
                     <td style="text-align: left; border-style: hidden;"><div align="center">Achievements</div></td>
 
                     <td style="text-align: left; border-style: hidden;"><div align="center">Achievements</div></td>
−
                     <td style="text-align: left; border-style: hidden;"><div align="center">Entrepreneurship</div></td>
+
                     <td style="text-align: left; border-style: hidden;"><div align="center">Project description</div></td>
 +
                    <td style="text-align: left; border-style: hidden;"><div align="center">Design</div></td>
 +
                    <td style="text-align: left; border-style: hidden;"><div align="center">Results</div></td>
 
                     <td style="text-align: left; border-style: hidden;"><div align="center">Practices and Polices</div></td>
 
                     <td style="text-align: left; border-style: hidden;"><div align="center">Practices and Polices</div></td>
−
                     <td style="text-align: left; border-style: hidden;"><div align="center">Safety</div></td>
+
                      
 
                    
 
                    
 
           </tr>
 
           </tr>
Line 91: Line 96:
 
<br />
 
<br />
  
−
<h2> <span class="mw-headline" id="PhyscoFilter_.E2.80.93_Clean_different."> The Boomerang system: </span></h2>
+
<h2> <span class="mw-headline" id="PhyscoFilter_.E2.80.93_Clean_different."> The Boomerang system: synthetic machine for cancer therapy </span></h2>
 
<p>Despite recent treatment advancements, cancer is still a major cause of mortality worldwide. One of the fundamental problems preventing the development of effective therapy is the difficulty to target cancer cells exclusively.  
 
<p>Despite recent treatment advancements, cancer is still a major cause of mortality worldwide. One of the fundamental problems preventing the development of effective therapy is the difficulty to target cancer cells exclusively.  
 
   <br />In Boomerang, we're engineering a genetic device based on a simple concept of AND logic gate: the activation of our CRISPR/Cas9-based system is dependent on the existence of two cancer-specific promoters that control the expression of Cas9 and gRNA, and the combination of these two will occur only in cancer cells. CRISPR/Cas9 system allows several applications of Boomerang: 1) disruption of genes essential for cancer survival; and 2) activation of suicide genes, or color proteins for cancer cell detection (e.g., for complete surgical removal).  <br />Our system can be potentially designed according to unique characteristics of a patient's tumor, paving the way to personalized medicine. We hope that our strategy will change the approach to cancer treatments.</p>
 
   <br />In Boomerang, we're engineering a genetic device based on a simple concept of AND logic gate: the activation of our CRISPR/Cas9-based system is dependent on the existence of two cancer-specific promoters that control the expression of Cas9 and gRNA, and the combination of these two will occur only in cancer cells. CRISPR/Cas9 system allows several applications of Boomerang: 1) disruption of genes essential for cancer survival; and 2) activation of suicide genes, or color proteins for cancer cell detection (e.g., for complete surgical removal).  <br />Our system can be potentially designed according to unique characteristics of a patient's tumor, paving the way to personalized medicine. We hope that our strategy will change the approach to cancer treatments.</p>
Line 138: Line 143:
 
   <table>
 
   <table>
 
<tr>
 
<tr>
−
         <td><div class="checklist" >
+
         <td style="border-style: hidden;"><div class="checklist" >
 
           <div class="medal">
 
           <div class="medal">
−
               <a href="https://2015.igem.org/Team:BGU_Israel/Judging">
+
               <a href="https://2015.igem.org/Team:BGU_Israel/Achievements">
 
                 <img src="https://static.igem.org/mediawiki/2015/b/b7/Medalcheck.png" height="150px" width="600px" />
 
                 <img src="https://static.igem.org/mediawiki/2015/b/b7/Medalcheck.png" height="150px" width="600px" />
 
               </a>  
 
               </a>  
 
           </div></div></td>
 
           </div></div></td>
−
          <td>  
+
        </tr></table>
−
          <center style="margin-top: 10px;">
+
<br /><br />
−
          <div id="clustrmaps-widget"></div><script type="text/javascript">                                             var _clustrmaps = { 'url': 'https://2015.igem.org/Team:BGU_Israel', 'user': 1176746, 'server': '3', 'id': 'clustrmaps-widget', 'version': 1, 'date': '2015-08-19', 'lang': 'en', 'corners': 'square' }; (function () { var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true; s.src = 'http://www3.clustrmaps.com/counter/map.js'; var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x); })();</script><noscript><a href="http://www3.clustrmaps.com/user/9bc11f4aa"><img src="http://www3.clustrmaps.com/stats/maps-no_clusters/2015.igem.org-Team-BGU_Israel-thumb.jpg" alt="Locations of visitors to this page" /></a></noscript>
+
<!-- finish HERE ----------------------------------------------------------------------------------------------->
−
            </center>
+
−
          </td></tr></table>
+
−
 
+
−
</p>
+
−
</div>
+
−
</div>
+
−
<p>
+
−
 
+
  
 
               </div>
 
               </div>
Line 161: Line 158:
 
       </div>
 
       </div>
 
   <div class="visualClear"></div>
 
   <div class="visualClear"></div>
−
 
+
  <br /><br /><br /><br /><br /><br /><br /><br />
 
</html>
 
</html>
  
 
{{BGU_Israel/footer}}
 
{{BGU_Israel/footer}}

Latest revision as of 16:02, 18 September 2015

Team:BGU Israel
Achievements
Project description
Design
Results
Practices and Polices

The Boomerang system: synthetic machine for cancer therapy

Despite recent treatment advancements, cancer is still a major cause of mortality worldwide. One of the fundamental problems preventing the development of effective therapy is the difficulty to target cancer cells exclusively.
In Boomerang, we're engineering a genetic device based on a simple concept of AND logic gate: the activation of our CRISPR/Cas9-based system is dependent on the existence of two cancer-specific promoters that control the expression of Cas9 and gRNA, and the combination of these two will occur only in cancer cells. CRISPR/Cas9 system allows several applications of Boomerang: 1) disruption of genes essential for cancer survival; and 2) activation of suicide genes, or color proteins for cancer cell detection (e.g., for complete surgical removal).
Our system can be potentially designed according to unique characteristics of a patient's tumor, paving the way to personalized medicine. We hope that our strategy will change the approach to cancer treatments.